Israeli-European Collaboration on Medical Tech R&D Praised
- EC commissioner Carlos Moedas visits Israeli technology hubs
- Moedas responsible for EC's Horizon 2020 research program
This article is for subscribers only.
Carlos Moedas -- the man responsible for the European Commission’s 77 billion-euro ($83.9 billion) seven-year Horizon 2020 research program -- visited Israel last week, where he named health research as a particularly valuable area of Europe’s cooperation with Israel.
As European Commissioner for Research, Science and Innovation, Moedas’ visit introduced him to Weizmann Institute researcher Yifat Merbl, whose protein research is aimed at finding ways to deal with cancer. At Jerusalem Venture Partners, he heard about the technology incubator partnership between government and industry and met cyber security company ThetaRay as well as two other JVP companies.